These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18678433)

  • 21. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
    Kaido T; Takada Y; Uemoto S
    Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
    [No Abstract]   [Full Text] [Related]  

  • 22. [Liver transplantation for hepatocellular carcinoma: status quo and experience in Kyushu University].
    Soejima Y; Taketomi A; Ikegami T; Yoshizumi T; Uchiyama H; Gion T; Sugimachi K; Nagata S; Maehara Y
    Fukuoka Igaku Zasshi; 2008 May; 99(5):95-101. PubMed ID: 18788452
    [No Abstract]   [Full Text] [Related]  

  • 23. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
    Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppression and hepatocellular carcinoma.
    Schlitt HJ; Mornex F; Shaked A; Trotter JF
    Liver Transpl; 2011 Oct; 17 Suppl 2():S159-61. PubMed ID: 21506251
    [No Abstract]   [Full Text] [Related]  

  • 25. Recurrence of hepatocellular carcinoma after liver transplantation presenting with massive intrahepatic bleeding.
    Donadon M; Giacomoni A; Lauterio A; Slim A; Pirotta V; Mangoni I; De Carlis L
    Liver Transpl; 2008 Feb; 14(2):259-61. PubMed ID: 18236411
    [No Abstract]   [Full Text] [Related]  

  • 26. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence of hepatocellular carcinoma after surgery: can it be avoided?
    Kew MC
    Hepatology; 1996 Sep; 24(3):741-2. PubMed ID: 8781354
    [No Abstract]   [Full Text] [Related]  

  • 28. Liver transplantation for hepatocellular carcinoma: the hepatitis C quandary.
    Yao FY
    Liver Transpl; 2007 Jun; 13(6):783-5. PubMed ID: 17538996
    [No Abstract]   [Full Text] [Related]  

  • 29. Salvage live donor liver transplantation for a second recurrence of hepatocellular carcinoma.
    Sotiropoulos GC; Treckmann JW; Molmenti EP; Schmitz KJ; Cicinnati VR; Paul A; Broelsch CE; Malagó M
    Transpl Int; 2008 Feb; 21(2):182-5. PubMed ID: 17971034
    [No Abstract]   [Full Text] [Related]  

  • 30. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
    Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
    Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence of hepatocellular carcinoma after liver transplantation: is immunosuppression a factor?
    Schwartz M; Konstadoulakis M; Roayaie S
    Liver Transpl; 2005 May; 11(5):494-6. PubMed ID: 15838915
    [No Abstract]   [Full Text] [Related]  

  • 33. Natural killer cells play divergent roles in shaping the outcome of hepatitis C virus recurrence following liver transplantation.
    Golden-Mason L
    Liver Transpl; 2009 Apr; 15(4):357-9. PubMed ID: 19326413
    [No Abstract]   [Full Text] [Related]  

  • 34. Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection.
    Ravaioli M; Grazi GL; Cescon M; Trevisani F; Piscaglia F; Ercolani G; Pinna AD
    Hepatology; 2009 Mar; 49(3):1056. PubMed ID: 19241485
    [No Abstract]   [Full Text] [Related]  

  • 35. Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
    Gouw AS; Balabaud C; Kusano H; Todo S; Ichida T; Kojiro M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S72-80. PubMed ID: 21714066
    [No Abstract]   [Full Text] [Related]  

  • 36. Surgical management of hepatocellular carcinoma: is the jury still out?
    Morris-Stiff G; Gomez D; de Liguori Carino N; Prasad KR
    Surg Oncol; 2009 Dec; 18(4):298-321. PubMed ID: 19062271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes mellitus and prognosis after curative therapy for hepatocellular carcinoma: alas, still grave for those who are hyperglycemic.
    Teoh NC; Fan JG
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1633-4. PubMed ID: 19120856
    [No Abstract]   [Full Text] [Related]  

  • 38. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria.
    D'Amico F; Schwartz M; Vitale A; Tabrizian P; Roayaie S; Thung S; Guido M; del Rio Martin J; Schiano T; Cillo U
    Liver Transpl; 2009 Oct; 15(10):1278-87. PubMed ID: 19790142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.
    Yang LY; Fang F; Ou DP; Wu W; Zeng ZJ; Wu F
    Ann Surg; 2009 Jan; 249(1):118-23. PubMed ID: 19106686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed?
    Volk M; Marrero JA
    Gastroenterology; 2008 May; 134(5):1612-4. PubMed ID: 18471530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.